KORU Medical Systems, Inc. — fact timeline

KORU Medical Systems, Inc. reported first quarter ended March 31, 2026 results: revenue $11.8 million, net income $0.8 million, EPS ($0.02) per diluted share. Guidance reaffirmed.

“financial results for the first quarter ended March 31, 2026. The Company also reiterated guidance for the full year 2026. Recent Highlights ● First quarter 2026 net revenues of $11.8 million grew 22% over the prior year period ● First quarter 2026 gross profit grew 20% over the prior year period to $7.2 million, with gross margin of 61.5% ● First quarter 2026 net”

KORU Medical Systems, Inc. amended term loan of $5,000,000 with HSBC Ventures USA Inc. at 5.50% (floor) maturing December 1, 2029.

“USA Inc., as lender, dated March 8, 2024, as amended (the “Loan and Security Agreement”), relating to a revolving credit facility in an aggregate principal amount not to exceed $5,000,000 (the “Revolver”) and a term loan facility in an aggregate principal amount not to exceed $5,000,000 (the “Term Loan” and collectively with the Revolver, the “Credit Facility”).”

KORU Medical Systems, Inc. amended revolving credit of $5,000,000 with HSBC Ventures USA Inc. at 5.50% (floor) maturing March 30, 2028.

“The Amendment extends the maturity of the $5,000,000 Revolver from December 31, 2026 to March 30, 2028”

KORU Medical Systems, Inc.: Amended and restated bylaws to enhance procedural mechanics and disclosure requirements for stockholder nominations and proposals (effective 2026-02-05).

“Effective February 5, 2026, the Board of Directors (the “Board”) of KORU Medical Systems, Inc. (the “Company”) unanimously adopted a resolution to amend and restate the Company’s By-laws in connection with the Securities and Exchange Commission rules regarding universal proxy cards and a periodic review of the bylaws.”

Kenneth Miller resigned as Chief Commercial Officer at KORU Medical Systems, Inc..

“On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.”

Brian Case was terminated as Chief Technology Officer at KORU Medical Systems, Inc..

“On July 18, 2024, the Company’s Board of Directors eliminated the position of Chief Technology Officer, currently held by Brian Case, effective as of September 16, 2024. Mr. Case’s employment with the Company will terminate concurrently with elimination of that position.”

KORU Medical Systems, Inc. shareholders approved Approval of the 2024 Omnibus Equity Incentive Plan at the 2024-05-09 meeting.

“Proposal 4: Approval of the 2024 Omnibus Equity Incentive Plan. The Company’s shareholders approved the adoption of the Company’s 2024 Omnibus Equity Incentive Plan. For Against Abstain Number of Shares 26,146,895 814,966 163,063”

KORU Medical Systems, Inc. shareholders approved Ratification of the appointment of independent registered accountants for the 2024 fiscal year at the 2024-05-09 meeting.

“Proposal 3: Ratification of the appointment of independent registered accountants for the 2024 fiscal year. The Company’s shareholders ratified the appointment of McGrail Merkel Quinn & Associates, P.C. as the company’s independent registered public accountants for the 2024 fiscal year. For Against Abstain Number of Shares 38,261,457 11,517 66,134”

KORU Medical Systems, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s executive officers at the 2024-05-09 meeting.

“Proposal 2: Approval, on an advisory basis, of the compensation of the Company’s executive officers. The Company’s shareholders, on an advisory basis, approved the compensation of the company’s executive officers. For Against Abstain Broker Non-Vote Number of Shares 26,409,104 541,923 173,897 11,214,184”

KORU Medical Systems, Inc. shareholders approved Election of Directors at the 2024-05-09 meeting.

“Proposal 1: Election of Directors The nominees for director set forth under “Nominees” below were elected to the Company’s board of directors. Number of Shares Nominees For Withheld Broker Non-Vote R. John Fletcher 25,929,278 1,195,646 11,214,184”

KORU Medical Systems, Inc. reported full year 2024 results: revenue $31.2 million to $32.2 million. Guidance reaffirmed.

“Reaffirmed full year 2024 revenue guidance of $31.2 million to $32.2 million, representing growth of 10% to 13% over the prior year.”

KORU Medical Systems, Inc. reported first quarter ended March 31, 2024 results: revenue 8.2 million, net income net loss of $1.9 million, EPS $(0.04) per diluted share.

“large volume subcutaneous infusion solutions, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights ● First quarter 2024 net revenues of $8.2 million, an 11% increase over the prior year and record high quarterly revenues ● Core business (U.S. and International) growth of 14% over the prior year, driven by overall SCIg market”

KORU Medical Systems, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue $28.5 million, net income ($13.7) million, or ($0.30) per share.

“issued guidance for the full year 2024. Recent Highlights ● Fourth quarter 2023 net revenues of $7.2 million, a 2% decrease from the prior year; Full year 2023 net revenues of $28.5 million, a 2% increase over the prior year ● Full year 6.7% Core business growth (U.S. and International) driven by overall SCIg market growth, share gains and expansion in new”

KORU Medical Systems, Inc. entered into Loan and Security Agreement with HSBC Ventures USA Inc. valued at $5,000,000 (effective 2024-03-08).

“On March 8, 2024, KORU Medical Systems, Inc. (the “Company”) entered into a loan and security agreement (the “Loan and Security Agreement”), by and between the Company and HSBC Ventures USA Inc., as lender providing for a revolving credit facility in an aggregate principal amount not to exceed $5,000,000 (the “Revolver”) and a term loan facility in an aggregate principal amount not to exceed $5,000,000”